Syneron Medical Ltd. (ELOS)
Symbol Info
Listed Symbol ELOS
Name Syneron Medical Ltd.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2016-12-31
Latest Fiscal Revenue $298,101,000
Latest Fiscal EPS $0.02
Price Info
21 Day Moving Average $10.9548
21 Day EMA $10.957420
50 Day Moving Average $10.9185
50 Day EMA $10.892440
200 Day EMA $9.823490
200 Day Moving Average 9.535280
52 Week High $11.43
52 Week Low $6.18
52 Week Change $48.048500
Alpha -0.007450
Beta 1.2651
Standard Deviation 0.090104
R2 0.149048
Periods 60
Share Information
10 Day Average Volume 362,599
20 Day Average Volume 318,151
30 Day Average Volume 289,584
50 Day Average Volume 588,397
Outstanding Shares 35,232,455
Float Shares 35,232,455
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 108
Institute Holdings Date 2017-06-30
Institute Bought Previous 3 Months 2,963,108
Institute Holdings Percent 70.300000
Institute Sold Previous 3 Months 5,744,108
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0749998
21 Day Percent Change 0.69%
30 Day Price Change $0.0500002
30 Day Percent Change 0.46%
Month To Date Price Change $0.0500
Month To Date Percent 0.46%
90 Day Price Change $-0.05
90 Day Percent Change -0.45%
Quarter To Date $0.050000
Quarter To Date Percent 0.46%
180 Day Price Change $2.400000
180 Day Percent Change 27.91%
200 Day Price Change $2.450000
200 Day Percent Change 28.65%
Year To Date $2.600000
Year To Date Percent 30.95%
Profile
Description Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments.
Details
Issue Type CS
Market Cap $387,557,005
Sec Type EQS
Auditor Kost Forer Gabbay & Kasierer
Total Shares Outstanding -
CEO Amit Meridor
Employees 817
Last Audit UQ
Classification
CIK 0001291361
Industry Medical Devices
Sector Healthcare
NAICS
Info
Address Industrial Zone
Tavor Building, P.O.B. 550
Yokneam Illit, 2069200
Website http://www.syneron.com
Facisimile +972 732442202
Telephone +972 732442200
Email infois@syneron.com
Key Ratios
Profitability
EBIT Margin 0.20
EBITDA Margin 3.2
Pre-Tax Profit Margin -1.4
Profit Margin Cont -2.22
Gross Margin 52.10
Profit Margin TOT -2.22
Income Statements
Revenue $221,319,000
Revenue Per Share $6.2817
Revenue 3 Years $2.99
Revenue 5 Years $1.80
Valuation Measures
PE Ratio -
Enterprise Value $334,641,005
Price To Sales 1.751124
Price To Free Cash 226.400000
PE High Last 5 Years -
Price To Book 1.9
Price To Cash Flow 43.0
PE Low Last 5 Years -
Price To Tangible Book 2.2
Financial Strength
Total Debt To Equity -
Int Coverage -0.8
Current Ratio 2.7
Leverage Ratio 1.3
Quick Ratio 1.8
Long Term Debt To Capital -
Assets
Receivables Turnover 3.8
Invoice Turnover 2.80
Assets Turnover 0.80
Management Effectiveness
Return Assets -1.55
Return On Equity -2.1
Return On Capital -2.03
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
ELOS
Syneron Me..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.